Edgewise Therapeutics Reports Third Quarter 2026 Financial Results
– Published the differentiated mechanism of action of EDG-7500 that targets the regulatory light chain – – Phase 3 trial for EDG-7500 in obstructive…
Newswire
– Published the differentiated mechanism of action of EDG-7500 that targets the regulatory light chain – – Phase 3 trial for EDG-7500 in obstructive…
- Revenues up 5% to $334.1 Million and Gross Billings up 3% to $2.40 Billion -
Dover Corporation (NYSE: DOV) today announced that it has completed the previously reported acquisition of Leistung Engineering Pvt. Ltd., which will…
Sequentially, net sales increased 5.7%, gross profit increased 28.3% and
Cirrus Logic Reports Fiscal Second Quarter Revenue of $559.5 Million
Received Regenerative Medicine Advanced Therapy (RMAT) Designation from U.S. FDA for TN-401 Gene Therapy for PKP2-Associated Arrhythmogenic Right…
Milestone reflects the firm's longstanding commitment to exclusively representing sellers in health care services mergers and acquisitions…
Positive Operating Cash Flow for the Third Consecutive Quarter Preparing for Major Mattress Portfolio Refresh to Strengthen Performance in 2027 LEHI,…
Youlife Group Inc. ("Youlife" or the "Company") (NASDAQ: YOUL), a leading blue-collar lifetime service provider in China, today announced that it has…
FDA Advisory Committee Voted in Favor of Approval of GRAIL's Galleri Multi-Cancer Early Detection Test Q3 Galleri®Test Volume Increased ~24% to More…
Carriage Services Announces Third Quarter 2026 Results, Updates 2026 Guidance